Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies

Abstract

SUMMARY In many natural and clinical settings, bacteria are associated with some type of biotic or abiotic surface that enables them to form biofilms, a multicellular lifestyle with bacteria embedded in an extracellular matrix. Staphylococcus aureus and Staphylococcus epidermidis, the most frequent causes of biofilm-associated infections on indwelling medical devices, can switch between an existence as single free-floating cells and multicellular biofilms. During biofilm formation, cells first attach to a surface and then multiply to form microcolonies. They subsequently produce the extracellular matrix, a hallmark of biofilm formation, which consists of polysaccharides, proteins, and extracellular DNA. After biofilm maturation into three-dimensional structures, the biofilm community undergoes a disassembly process that leads to the dissemination of staphylococcal cells. As biofilms are dynamic and complex biological systems, staphylococci have evolved a vast network of regulatory mechanisms to modify and fine-tune biofilm development upon changes in environmental conditions. Thus, biofilm formation is used as a strategy for survival and persistence in the human host and can serve as a reservoir for spreading to new infection sites. Moreover, staphylococcal biofilms provide enhanced resilience toward antibiotics and the immune response and impose remarkable therapeutic challenges in clinics worldwide. This review provides an overview and an updated perspective on staphylococcal biofilms, describing the characteristic features of biofilm formation, the structural and functional properties of the biofilm matrix, and the most important mechanisms involved in the regulation of staphylococcal biofilm formation. Finally, we highlight promising strategies and technologies, including multitargeted or combinational therapies, to eradicate staphylococcal biofilms.

Characterization of Staphylococcus aureus Isolates From Cases of Clinical Bovine Mastitis on Large-Scale Chinese Dairy Farms

“…The emergence of MDR S. aureus has become a growing public health concern. In this study, 54.5% (6/11) of MDR S. aureus isolates belong to spa type t2196-agr I. Staphylococcal biofilms can enhance the resistance of S. aureus to antibiotics (38). In this investigation, the percentage of MDR isolates was significantly higher in moderate biofilm producers than in weak biofilm producers.…”

Virulence Factors in Coagulase-Negative Staphylococci

“…To form the complex structure displayed in biofilms, bacteria have to tightly coordinate every single step of the process. As such, there are several regulatory systems involved in biofilm formation by staphylococcal species, the agr QS system being one of the best characterized (reviewed in [37,128,129]).…”

Antibiotics in Bone Cements Used for Prosthesis Fixation: An Efficient Way to Prevent Staphylococcus aureus and Staphylococcus epidermidis Prosthetic Joint Infection

“…Biofilms are communities of bacteria embedded in an extracellular matrix. The formation of biofilm is classically described in three main phases: (i) initial attachment, (ii) production of extracellular matrix and cell proliferation, and (iii) biofilm structuring and cell detachment ( 7 ). The first phase, initial attachment, is critical for biofilm formation.…”